Citation

BibTex format

@article{Cho:2025:10.1038/s44321-025-00267-7,
author = {Cho, H-J and Smith, J and Switzer, CH and Louka, E and Charles, RL and Prysyazhna, O and Schroder, E and Fernandez-Caggiano, M and de, Jesus DS and Eminaga, S and Yin, X and Yang, X and Lynham, S and Mayr, M and Morales, V and Bianchi, K and Rajeeve, V and Cutillas, PR and Mead, AJ and Eaton, P},
doi = {10.1038/s44321-025-00267-7},
journal = {EMBO MOLECULAR MEDICINE},
pages = {2115--2136},
title = {SFX-01 is therapeutic against myeloproliferative disorders caused by activating mutations in Shp2},
url = {http://dx.doi.org/10.1038/s44321-025-00267-7},
volume = {17},
year = {2025}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - Cho,H-J
AU  - Smith,J
AU  - Switzer,CH
AU  - Louka,E
AU  - Charles,RL
AU  - Prysyazhna,O
AU  - Schroder,E
AU  - Fernandez-Caggiano,M
AU  - de,Jesus DS
AU  - Eminaga,S
AU  - Yin,X
AU  - Yang,X
AU  - Lynham,S
AU  - Mayr,M
AU  - Morales,V
AU  - Bianchi,K
AU  - Rajeeve,V
AU  - Cutillas,PR
AU  - Mead,AJ
AU  - Eaton,P
DO  - 10.1038/s44321-025-00267-7
EP  - 2136
PY  - 2025///
SN  - 1757-4676
SP  - 2115
TI  - SFX-01 is therapeutic against myeloproliferative disorders caused by activating mutations in Shp2
T2  - EMBO MOLECULAR MEDICINE
UR  - http://dx.doi.org/10.1038/s44321-025-00267-7
VL  - 17
ER  -
Download